List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 24 studies with search of: Friedreich's Ataxia
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Lu AA24493;   Drug: Placebo
2 Completed A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: placebo;   Drug: deferiprone
3 Completed Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
4 Completed Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling
Condition: Friedreich Ataxia
Intervention:
5 Terminated Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: varenicline;   Drug: placebo
6 Completed Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
7 Completed A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Deferiprone oral solution 100mg/mL;   Drug: Deferiprone oral solution 100 mg/mL
8 Completed
Has Results 		Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: Idebenone;   Drug: Placebo
9 Active, not recruiting Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
Condition: Friedreich's Ataxia
Interventions: Drug: pioglitazone;   Drug: Placebo
10 Recruiting Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
11 Recruiting Safety and Efficacy of Intravenous Immune Globulin in Treating Friedreich's Ataxia and Spinocerebellar Ataxia
Conditions: Friedreich's Ataxia;   Spinocerebellar Ataxia Type 3
Intervention: Biological: IVIG
12 Completed A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
Condition: Friedreich's Ataxia
Interventions: Drug: idebenone;   Drug: Placebo
13 Recruiting A Study of Resveratrol as Treatment for Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Resveratrol
14 Completed Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Intervention: Drug: Epoetin alfa
15 Completed Safety Study of Idebenone to Treat Friedreich's Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Idebenone
16 Completed
Has Results 		Study to Assess the Safety and Tolerability of Idebenone in the
Condition: Friedreich's Ataxia
Intervention: Drug: Idebenone
17 Not yet recruiting Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
18 Completed Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: EGb 761 120 mg;   Drug: Placebo
19 Completed Iron-Chelating Therapy and Friedreich Ataxia
Condition: Friedreich Ataxia
Intervention: Drug: Iron chelating intervention
20 Completed Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
Condition: Friedreich's Ataxia
Interventions: Drug: alpha-tocopherolquinone (A0001);   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-24)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services